INSTANTINO 0.25MG/5ML INJECTION

Content Reviewed By:

Written By:

• INSTANTINO 0.25MG/5ML INJECTION is a medication that belongs to a class of drugs known as serotonin receptor antagonists. Its primary function is to alleviate nausea and vomiting by counteracting the effects of serotonin, a naturally occurring substance in the body that can trigger these symptoms. Chemotherapy can stimulate the chemoreceptor trigger zone (CTZ) in the brain, which contains serotonin receptors. When these receptors are activated, they send signals that lead to vomiting.
• INSTANTINO 0.25MG/5ML INJECTION works by selectively blocking these serotonin receptors in the CTZ. By preventing serotonin from binding to its receptors, the medication effectively interrupts the signals that cause nausea and vomiting. This targeted action helps to reduce the frequency and severity of these unpleasant symptoms, improving the patient's overall comfort and well-being during chemotherapy or other treatments that may induce nausea.
• The precise mechanism of action of INSTANTINO 0.25MG/5ML INJECTION ensures that it specifically addresses the root cause of chemotherapy-induced nausea and vomiting. By blocking the serotonin signals, it provides relief from these debilitating symptoms, allowing patients to better tolerate their treatments and maintain a higher quality of life. Its effectiveness and targeted approach make it a valuable tool in managing nausea and vomiting associated with various medical conditions and treatments.

• INSTANTINO 0.25MG/5ML INJECTION will be administered to you by a qualified healthcare professional, typically in a hospital or clinical setting. It is crucial that this medication is given under the supervision of trained medical personnel who can monitor your response and manage any potential side effects. The timing of the injection is carefully coordinated with your treatment plan.
• Generally, INSTANTINO 0.25MG/5ML INJECTION is administered approximately 30 minutes prior to receiving chemotherapy, which is anti-cancer medication. This pre-emptive administration helps to mitigate potential side effects associated with chemotherapy. In other cases, it may be administered immediately before you receive anaesthesia prior to undergoing a surgical procedure. The specific timing will be determined by your doctor based on your individual needs and the nature of your treatment.
• Your healthcare provider will determine the correct dosage and administration schedule for INSTANTINO 0.25MG/5ML INJECTION. It's important to follow their instructions carefully and to discuss any concerns or questions you may have about the medication or its administration. Do not attempt to self-administer this medication.